(SMMT) Summit Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Summit Therapeutics | (SMMT) share price targets
Complete technical analysis of Summit Therapeutics (SMMT) by charts plus indicators, forecast predictions and share price targets for Summit Therapeutics (SMMT)
Summit Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-11 View latest technical analysis
10 day averaged volume of Summit Therapeutics is 2763456
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Tue Mar 2025 | 18.50 | 18.08 | 18.87 | 17.42 | 1.023 times |
| 10 Mon Mar 2025 | 17.99 | 17.18 | 18.40 | 16.55 | 1.297 times |
| 07 Fri Mar 2025 | 17.78 | 18.86 | 18.97 | 17.70 | 1.234 times |
| 06 Thu Mar 2025 | 18.99 | 18.89 | 19.92 | 18.52 | 0.681 times |
| 05 Wed Mar 2025 | 19.55 | 18.91 | 19.59 | 18.76 | 0.583 times |
| 04 Tue Mar 2025 | 19.09 | 18.56 | 19.37 | 18.34 | 0.967 times |
| 03 Mon Mar 2025 | 19.13 | 20.80 | 21.38 | 18.84 | 1.028 times |
| 28 Fri Feb 2025 | 20.69 | 18.74 | 20.77 | 18.50 | 1.018 times |
| 27 Thu Feb 2025 | 18.49 | 18.60 | 19.26 | 17.96 | 0.799 times |
| 26 Wed Feb 2025 | 18.30 | 18.55 | 19.56 | 18.27 | 1.041 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 18.2 as stoploss in an intra day buy trade for a target of 19.76. However, stock will show a bearish move below 18.2.
Share price targets for Summit Therapeutics (SMMT)
| Target Type | Value |
| Downside Target | 16.46 |
| Downside Target | 17.70 |
| Downside Target | 18.42 |
| Upside Target | 18.87 |
| Upside Target | 19.55 |
| Upside Target | 20.43 |
| Upside Target | 21.38 |
| Upside Target | 22.53 |
| Upside Target | 22.71 |
| Upside Target | 22.75 |
| Upside Target | 24.18 |
| Upside Target | 25.00 |
Intraday share price targets for Summit Therapeutics (SMMT)
| Target Type | Value |
| Downside Intraday Target | 17.08 |
| Downside Intraday Target | 15.65 |
| Upside Intraday Target | 19.4 |
| Upside Intraday Target | 20.29 |
| Downside Intraday Target | 17.97 |
Weekly technical analysis of Summit Therapeutics (SMMT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Tue Mar 2025 | 18.50 | 17.18 | 18.87 | 16.55 | 0.516 times |
| 07 Fri Mar 2025 | 17.78 | 20.80 | 21.38 | 17.70 | 0.67 times |
| 28 Fri Feb 2025 | 20.69 | 22.46 | 22.71 | 17.70 | 1.886 times |
| 21 Fri Feb 2025 | 22.12 | 21.52 | 24.18 | 20.43 | 0.859 times |
| 14 Fri Feb 2025 | 21.37 | 20.71 | 22.75 | 18.42 | 1.427 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Summit Therapeutics (SMMT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Tue Mar 2025 | 18.50 | 20.80 | 21.38 | 16.55 | 0.394 times |
| 28 Fri Feb 2025 | 20.69 | 20.54 | 24.18 | 17.70 | 0.859 times |
| 31 Fri Jan 2025 | 21.50 | 17.97 | 25.00 | 16.46 | 1.701 times |
| 31 Tue Dec 2024 | 17.84 | 18.84 | 19.55 | 16.83 | 0.928 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Summit Therapeutics (SMMT)
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Summit Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.77 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Summit Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.77 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.